Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 16/20 | 0.61 |
| ▸ | SYK | P43405 | 3/20 | 0.56 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13254722 | 0.93 | IL23R (0.54) | IL23RSYKTFPI | |
| SCHEMBL29531748 | 0.88 | OPRD1 (0.53) | IL23R | |
| SCHEMBL25627431 | 0.87 | APC (0.52) | IL23RTFPI | |
| SCHEMBL30061253 | 0.86 | F2 (0.54) | IL23RTFPI | |
| SCHEMBL29611494 | 0.86 | BACE1 (0.58) | IL23RTFPI | |
| SCHEMBL31369291 | 0.85 | KISS1R (0.61) | IL23RTFPI | |
| SCHEMBL24324740 | 0.84 | NPY1R (0.55) | — | |
| SCHEMBL15317805 | 0.84 | OPRM1 (0.56) | IL23RSYK | |
| SCHEMBL29611881 | 0.84 | F2 (0.59) | IL23RTFPI | |
| SCHEMBL26873736 | 0.83 | OPRM1 (0.48) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100196282-A1 | OPTICAL IMAGING AGENTS | GE HEALTHCARE LIMITED (GB) | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196282-A1 | OPTICAL IMAGING AGENTS | VIP, SSTR4, NGLY1 | IL23R 3090/4885SYK 295/4885TFPI 1977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.